Condition: Diabetic Foot Ulcer · Diabetic Foot · Foot Ulcer Due to Type 2 Diabetes Mellitus · Sponsor: MiMedx Group, Inc.
This study will evaluate two human amnion/chorion membrane (ppLHACM) products and Standard of Care (SOC) versus SOC alone in the closure of nonhealing diabetic foot ulcers (DFUs).
This description comes directly from the study's public registry record.
Brittany Bonafide · 888-960-1343 · bbonafide@serenagroups.com
Thomas Serena, MD · tserena@serenagroups.com
Always discuss trial participation with your own doctor first.
| SerenaGroup - Monroeville | Monroeville, Pennsylvania, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06600724